Century Therapeutics, Inc. - stock earnings
IPSC Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -39.4 million USD | 268000 USD |
2023Q3 | -32.7 million USD | 148000 USD |
2023Q2 | -33.3 million USD | 99000 USD |
2023Q1 | -31.3 million USD | 1.7 million USD |
2022Q4 | -31.7 million USD | 521000 USD |
2022Q3 | -30.7 million USD | 2.2 million USD |
2022Q2 | -31.0 million USD | 1.4 million USD |
2022Q1 | -37.5 million USD | 1.1 million USD |
2021Q4 | -28.2 million USD | ? USD |
2021Q3 | -26.0 million USD | ? USD |
2021Q2 | -23.3 million USD | ? USD |
2021Q1 | -18.3 million USD | ? USD |
2020Q4 | -15.5 million USD | ? USD |
2020Q3 | -13.1 million USD | ? USD |
2020Q2 | -15.3 million USD | ? USD |
2020Q1 | -9.7 million USD | ? USD |
2016Q4 | ? USD | 470.3 million USD |
2015Q4 | ? USD | 950.8 million USD |
IPSC Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -136.7 million USD | 2.2 million USD |
2022 | -130.9 million USD | 5.2 million USD |
2021 | -95.8 million USD | 1.1 million USD |
2020 | -54.7 million USD | ? USD |
2019 | -246.0 million USD | ? USD |
2016 | ? USD | 470.3 million USD |
2015 | ? USD | 950.8 million USD |
IPSC
Price: $2.88
52 week price:
Earnings Per Share: -2.30 USD
P/E Ratio: -1.95
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 69234
Market Capitalization: 245.0 million